Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 years Ruchika Sharma6 Dec 2022 11:30 AM ISTNew York: Pfizer and BioNTech have announced that the companies have submitted an application to the U.S. Food and Drug Administration (USFDA) for...
COVID trials improved diversity recruiting, says Moderna Top Scientist Ruchika Sharma3 Dec 2022 4:00 PM ISTNew York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...
CDSCO nod to World's first intra-nasal COVID vaccine for restricted use Ruchika Sharma2 Dec 2022 12:00 PM ISTVaccine is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
Shionogi seeks Japenese nod for COVID Recombinant Protein-based Vaccine S-268019 Ruchika Sharma27 Nov 2022 1:30 PM ISTOsaka: Shionogi & Co., Ltd. has announced that it has filed for manufacturing and sales approval of S-268019, a recombinant protein-based...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Novavax claim on COVID vaccine deal breach rejected by Gavi Ruchika Sharma25 Nov 2022 2:30 PM ISTIn response to Gavi's statement, Novavax reiterated that it has been ready to meet its commitment to manufacture and deliver doses for the COVAX...
Patient demands Rs 10 crore compensation for alleged paralysis after Covishield administration: Kerala HC issues notice to SII Ruchika Sharma19 Nov 2022 4:00 PM ISTThe petitioner submitted that her husband suffered a high fever on the same day that he received the vaccine and thereafter, his condition...
Scientific approach followed in Covaxin approval: Govt rebuts all allegations on Bharat Biotech Covaxin hurried approval Ruchika Sharma17 Nov 2022 3:30 PM ISTNew Delhi: There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine – Covaxin, "had to skip certain...
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 2:00 PM IST-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Bharat Biotech Covaxin 50 million doses set to expire early 2023 due to poor demand Ruchika Sharma7 Nov 2022 1:00 PM ISTHyderabad: Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no...
Moderna COVID vaccine sales forecasts fall short for 2022, 2023 Ruchika Sharma6 Nov 2022 10:00 AM ISTCambridge: Moderna Inc has cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook...
